C4 Therapeutics, Inc. (CCCC)

C4 Therapeutics Revenue

C4 Therapeutics had revenue of $20.04M in the twelve months ending March 31, 2024, down -26.34% year-over-year. Revenue in the quarter ending March 31, 2024 was $3.04M, a -19.15% decrease year-over-year. In the year 2023, C4 Therapeutics had annual revenue of $20.76M, a decrease of -33.25%.

• Revenue (ttm): $20.04M
• Revenue Growth: -26.34%
• P/S Ratio: 19.44
• Revenue / Employee: $138,179
• Employees: 145
• Market Cap: 389.44M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	20.76M	-10.34M	-33.25%
Dec 31, 2022	31.10M	-14.69M	-32.08%
Dec 31, 2021	45.79M	12.59M	37.93%
Dec 31, 2020	33.20M	11.81M	55.25%
Dec 31, 2019	21.38M	2.02M	10.42%
Dec 31, 2018	19.36M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.